[Other] The Lancet Diabetes and Endocrinology

maryamawadhpdc Post time Yesterday 23:50 | Show all posts |Read mode
This post will be closed automatically in 2026-07-28 23:48
Reward30points

Setmelanotide in patients aged 2每5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
Prof Jes迆s Argente, MD PhDa,b,c Send email to [email protected] ∙ Prof Charles F Verge, PhDd ∙ Uzoma Okorie, MDe ∙ Ilene Fennoy, MDf ∙ Megan M Kelsey, MDg ∙ Casey Cokkinias, MPHh ∙ et al. Show more
Affiliations & Notes
Article Info
Publication History:
Published November 13, 2024
DOI: 10.1016/S2213-8587(24)00273-0 External Link
Also available on ScienceDirect External Link
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.


https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00273-0/abstract

https://doi.org/10.1016/S2213-8587(24)00273-0

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list